Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Cancer Diagnosis Program (CDP) — Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program (CDP) Biorepositories & Biospecimen Research Branch (BBRB)
Contact NExT
Show menu
Search this site
Last Updated: 07/25/14

caBIG™ Tools

One of the most challenging issues for researchers and biorepositories has been the absence of information technology tools and infrastructure to facilitate the appropriate collection, processing, archiving, and dissemination of biospecimens to the research community, not only within an individual medical institution but also in a network across multiple institutions.

  • caTissue core will address all aspects of donor enrollment and informed consent, collection and tracking of samples.
  • caTissue CAE will address annotation of biospecimens with molecular and clinical data.
  • caTIES will allow extraction of structured data from free text pathology reports.
  • caBIG™ tools are designed with security considerations to support patient privacy and data access restrictions, including those aspects covered by the Common Rule and HIPAA (Health Insurance Portability and Accountability Act). Visit http://www.hhs.gov/ocr/hipaa/ or http://privacyruleandresearch.nih.gov/ to learn more about HIPAA. Information about the Common Rule (45 CFR 46) may be found at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html. Further information can be found here.

Additional caBIG™ information can be found here:

OBBR caBIG™ Fact Sheet (PDF Documnet: 35 KB)

Implementing caBIG™ (PDF Documnet: 80 KB)

caBIG™ Tissue/Biospecimen Banking and Technology Tools Knowledge Center Forum

caBIG™ Data Sharing and Intellectual Capital Knowledge Center Forum